1. Home
  2. BCRX vs DAC Comparison

BCRX vs DAC Comparison

Compare BCRX & DAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BioCryst Pharmaceuticals Inc.

BCRX

BioCryst Pharmaceuticals Inc.

HOLD

Current Price

$9.01

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$120.79

Market Cap

2.1B

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCRX
DAC
Founded
1986
1972
Country
United States
Greece
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Marine Transportation
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.1B
IPO Year
1995
2006

Fundamental Metrics

Financial Performance
Metric
BCRX
DAC
Price
$9.01
$120.79
Analyst Decision
Strong Buy
Buy
Analyst Count
11
2
Target Price
$20.82
$112.50
AVG Volume (30 Days)
3.9M
50.9K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
2.97%
EPS Growth
381.40
N/A
EPS
1.21
N/A
Revenue
$25,186,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.55
N/A
P/E Ratio
$7.34
$4.01
Revenue Growth
N/A
N/A
52 Week Low
$6.00
$79.48
52 Week High
$11.31
$121.21

Technical Indicators

Market Signals
Indicator
BCRX
DAC
Relative Strength Index (RSI) 48.21 63.79
Support Level $8.73 $91.64
Resistance Level $9.14 N/A
Average True Range (ATR) 0.36 2.46
MACD -0.10 0.28
Stochastic Oscillator 32.68 95.09

Price Performance

Historical Comparison
BCRX
DAC

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

Share on Social Networks: